SCHEMBL4025384

SCHEMBL4025384

Cc1cc(N2CCNC2=O)sc1C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
CYP3A4 P08684 3/20 0.35
CYP1A2 P05177 2/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CMA1 P23946 2/20 0.34
PKM P14618 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
ALDH1A1 P00352 3/20 0.32
POLB P06746 1/20 0.32
GFER P55789 1/20 0.31
CYP2C9 P11712 2/20 0.31
MEN1 O00255 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL243170 0.82 ALOX15 (0.45) SMN1; SMN2TSHRHSD17B10CMA1PKM
SCHEMBL3573012 0.78 CYP3A4 (0.38) SMN1; SMN2CYP3A4CYP1A2TSHRHSD17B10
SCHEMBL4023755 0.73 PIK3CD (0.54) SMN1; SMN2CYP3A4CYP1A2TSHRHSD17B10
SCHEMBL3119596 0.70 PIK3CD (0.56) SMN1; SMN2HSD17B10PIK3CDPIK3CAPIK3CB
SCHEMBL245119 0.70 SCD (0.44) RORC
SCHEMBL243779 0.69 SCD (0.60) TSHRPKMRAB9AALDH1A1POLB
SCHEMBL28779004 0.67 RORC (0.36) RORCSMN1; SMN2TSHRNPSR1RAB9A
SCHEMBL242263 0.67 EP300 (0.45) RORCSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL14047537 0.67 NOTUM (0.36) RORC
SCHEMBL27756804 0.67 RORC (0.44) RORCSMN1; SMN2TSHRHSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054408-A2 HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LIPID LEVEL Novartis Ag (CH) 2009-05-06 EP disclosed
WO-2008127349-A2 HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LIPID LEVEL NOVARTIS AG (CH) 2008-10-23 WO disclosed